menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
ReachMD Faculty

Public Profile

David Porter, MD
David Porter, MD

    Dr. David Porter is a professor of medicine at the University of Pennsylvania School of Medicine and director of stem cell transplantation and immunotherapy at the Hospital of the University of Pennsylvania in Philadelphia. He is a graduate of the University of Rochester and earned a medical degree at Brown University in Providence, Rhode Island. He completed internship and residency at Boston University Hospital, and fellowship training at Brigham and Women's Hospital and Harvard Medical School. He chairs or serves on multiple local, national and international committees focused on hematopoietic stem cell transplantation.

    Dr. Porter has expertise in all aspects of autologous, related and unrelated donor stem cell transplantation, and has developed or been an active participant in numerous local and national research activities. He is an accomplished clinical investigator and has published extensively in the field of stem cell transplantation and hematologic malignancies. His principal research interests are in development of novel methods of stem cell transplantation and of allogeneic adoptive immunotherapy. Research highlights include novel trials designed to enhance graft-vs-tumor activity at the time of transplant, after non-myeloablative therapy, and for relapse after stem cell transplantation.

    Dr. Porter is a member of the American Society of Hematology, the American Society of Clinical Oncology, the International Society for Cellular Therapy, and the American Society of Blood and Marrow Transplantation. In 2007 Dr. Porter was awarded the Leukemia and Lymphoma Society Service to Mankind Award, which is bestowed for "dedicated service to the highest standards of the medical profession, his humanistic approach to patient care, and his tireless efforts in researching cures for blood cancers." He has authored more than 100 research articles, abstracts, and book chapters, is an associate editor for the American Journal of Hematology and has served as a manuscript reviewer for numerous medical journals, including Blood, Annals of Internal Medicine and The New England Journal of Medicine.

    Schedule17 Apr 2024